Showing results (1-10 of 95) with videos related to
Sort By:
Pageof 10
Hospital & Community Psychiatry|April 1, 1984
Movement disorders in the psychiatric patientD A Moros, M D YahrArchives of Neurology|January 1, 1991
Early combination of selegiline and low-dose levodopa as initial symptomatic therapy in Parkinson's disease. Experience in 26 patients receiving combined therapy for 26 monthsT S Elizan, D A Moros, M D YahrArchives of Neurology|December 1, 1989
Selegiline as an adjunct to conventional levodopa therapy in Parkinson's disease. Experience with this type B monoamine oxidase inhibitor in 200 patientsT S Elizan, M D Yahr, D A Moros, et al.Archives of Neurology|December 1, 1989
Selegiline use to prevent progression of Parkinson's disease. Experience in 22 de novo patientsT S Elizan, M D Yahr, D A Moros, et al.Acta Neurologica Scandinavica. Supplementum|January 1, 1993
Parkinson's disease: new approaches to diagnosis and treatmentM D YahrJournal of Neural Transmission|January 1, 1978
Overview of present day treatment of Parkinson's diseaseM D YahrThe Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|February 1, 1984
Limitations of long term use of antiparkinson drugsM D YahrPageof 10